DK0789764T3 - Ny familie af proteaseinhibitorer og andre biologisk aktive substanser - Google Patents

Ny familie af proteaseinhibitorer og andre biologisk aktive substanser

Info

Publication number
DK0789764T3
DK0789764T3 DK95937853T DK95937853T DK0789764T3 DK 0789764 T3 DK0789764 T3 DK 0789764T3 DK 95937853 T DK95937853 T DK 95937853T DK 95937853 T DK95937853 T DK 95937853T DK 0789764 T3 DK0789764 T3 DK 0789764T3
Authority
DK
Denmark
Prior art keywords
relates
biologically active
inhibitors
active substances
protease inhibitors
Prior art date
Application number
DK95937853T
Other languages
English (en)
Inventor
Gerard Voerman
Original Assignee
Vitaleech Bioscience N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitaleech Bioscience N V filed Critical Vitaleech Bioscience N V
Application granted granted Critical
Publication of DK0789764T3 publication Critical patent/DK0789764T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK95937853T 1994-10-28 1995-10-27 Ny familie af proteaseinhibitorer og andre biologisk aktive substanser DK0789764T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94117053 1994-10-28
EP95103637 1995-03-14
PCT/EP1995/004223 WO1996013585A1 (en) 1994-10-28 1995-10-27 A novel family of protease inhibitors, and other biologic active substances

Publications (1)

Publication Number Publication Date
DK0789764T3 true DK0789764T3 (da) 2002-04-22

Family

ID=26135896

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95937853T DK0789764T3 (da) 1994-10-28 1995-10-27 Ny familie af proteaseinhibitorer og andre biologisk aktive substanser

Country Status (11)

Country Link
US (1) US6239106B1 (da)
EP (1) EP0789764B1 (da)
JP (1) JP4278175B2 (da)
AT (1) ATE211765T1 (da)
AU (1) AU3870195A (da)
CA (1) CA2203827A1 (da)
DE (1) DE69524971T2 (da)
DK (1) DK0789764T3 (da)
ES (1) ES2171563T3 (da)
PT (1) PT789764E (da)
WO (1) WO1996013585A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997017981A1 (en) * 1995-11-13 1997-05-22 Gerard Voerman Anti-viral isolates obtainable from leeches
AUPO427596A0 (en) * 1996-12-20 1997-01-23 Cooperative Research Centre For Tropical Plant Pathology Anti-microbial protein
EP0875564A1 (en) * 1997-05-02 1998-11-04 Gerard Voerman Biologically active extract from the leech 'Limnatis nilotica'
FR2763944B1 (fr) * 1997-06-03 2000-12-15 Centre Nat Rech Scient Nouveaux derives de coumarines, leurs procedes de preparation et leur application comme medicaments en tant qu'inhibiteurs de proteases
US6232287B1 (en) * 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
US6774107B1 (en) * 1999-03-18 2004-08-10 Merck Patent Gmbh Protein for blocking platelet adhesion
JP2016528234A (ja) * 2013-08-05 2016-09-15 フォールマン、ジェラルド 喫煙の悪影響を減らす新規手段
WO2016020070A1 (en) * 2014-08-05 2016-02-11 Gerard Voerman Mutants of leech derived neutrophil elastase inhibitors and uses thereof
CN105646702B (zh) * 2016-04-13 2019-03-01 中国科学院昆明动物研究所 菲牛蛭Kazal型胰蛋白酶抑制剂Bdellin-HM及其编码基因和应用
CA3073685A1 (en) * 2017-08-27 2019-03-07 Anti-Viral Technologies, Llc Methods and compositions for the antiviral use of synthetic lysine analogs and mimetics
US11262125B2 (en) * 2018-01-02 2022-03-01 Praxair Technology, Inc. System and method for flexible recovery of argon from a cryogenic air separation unit
WO2022232516A1 (en) * 2021-04-30 2022-11-03 The Regents Of The University Of California Cartilage treatment for use in eyelid reconstruction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86857A (en) * 1988-06-24 1994-04-12 Yissum Res Dev Co Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same
US5783421A (en) * 1993-04-09 1998-07-21 Bio-Technology General Corp. DNA encoding novel polypeptide having Factor Xa inhibitory activity

Also Published As

Publication number Publication date
ATE211765T1 (de) 2002-01-15
DE69524971T2 (de) 2002-08-29
ES2171563T3 (es) 2002-09-16
WO1996013585A1 (en) 1996-05-09
US6239106B1 (en) 2001-05-29
CA2203827A1 (en) 1996-05-09
JPH10509589A (ja) 1998-09-22
DE69524971D1 (de) 2002-02-14
EP0789764B1 (en) 2002-01-09
AU3870195A (en) 1996-05-23
PT789764E (pt) 2002-06-28
EP0789764A1 (en) 1997-08-20
JP4278175B2 (ja) 2009-06-10

Similar Documents

Publication Publication Date Title
DK0762888T3 (da) Copolymer-1 forbedringer i præparater af copolymerer
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
ATE270557T1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
DK0789764T3 (da) Ny familie af proteaseinhibitorer og andre biologisk aktive substanser
DE69620877T2 (de) Arzneimittelformulierungen für il-12
FR2762843B1 (fr) Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
ATE184009T1 (de) Halichondrine: zytotoxische polyäther-makrolide
FR2842209B1 (fr) Nouvelle protease aspartique dite saspase et son utilisation dans le domaine cosmetique et therapeutique
EP0830456A4 (en) ISOLATED PROTEIN B NUCLEIC ACID MOLECULE REGULATED BY Fe (FrpB) AND VACCINE USING THE SAME
SE9101838D0 (sv) Novel peptides and their use
DK0754229T3 (da) Afamin: et humant serum albumin-lignende protein
EP0830130A4 (en) TNF-ALPHA CONVERTING ENZYME
BR9407693A (pt) Sequência nucleotídica vetor composiçao farmacêutica utilizaçao do vetor e de um composto
FR2692282B1 (fr) Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
FR2624854B1 (fr) Nouveaux sulfonamides du benzylidene camphre derivant d'aminoacides et leur application en cosmetique, notamment en tant que filtres solaires
YU200091A (sh) Delecioni mutanti ahasarezistentni na herbicide
EP0272174A3 (fr) Préparations d'adenyl cyclase purifiées, procédé d'obtention de ces préparations et leurs applications biologiques
RS49520B (sr) Antimikrobno aktivne smeše
DK0490383T3 (da) Peptider af HIV-gag-proteinet, fremstilling og anvendelse deraf
NZ228208A (en) Eglin compounds (hurudin) and protease inhibitor pharmaceutical compositions
FR2661188B1 (fr) Nouveaux vecteurs de clonage et/ou d'expression, procede de preparation et leur utilisation.
ATE146526T1 (de) Neues thrombininhibitorisches protein aus zecken